SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-09

AUTHORS

V. Deroche-Gamonet, M. Le Moal, P. Piazza, P. Soubrié

ABSTRACT

RATIONALE: The endogenous cannabinoid system is thought to play a role in reinforcement processes. OBJECTIVES: We tested the effects of five doses of the cannabinoid receptor 1 (CB1) antagonist SR141716 [0, 0.3, 1, 3 and 10 mg/kg intraperitoneal (IP)] on intracranial self-stimulation at the level of the median forebrain bundle (MFB). Self-stimulation was assessed 30 min and 210 min after SR141716 administration. We compared the effect of SR141716 with the effect of a decrease in the magnitude of stimulation (-100 microA) and the effects of a cocaine injection (1, 5 and 10 mg/kg IP). METHODS: a protocol of rate-frequency curve for self-stimulation was applied. Two rate-frequency curves were established daily, 3 h apart. The frequency required to produce half-maximal performance (M50) and the maximal performance (RMax) were used as the parameters to characterize the rate-frequency functions. RESULTS: SR141716 decreased the sensitivity to the electrical brain stimulation. SR141716 induced a shift to the right of the rate-frequency curve. This effect depended on the dose administered and the time after injection. Thirty minutes after the injection, 1, 3 and 10 mg/kg SR141716 induced a significant decrease in sensitivity to electrical stimulation, as shown by an elevation in the M50 value. RMax showed a tendency to decrease with increasing doses. At 210 min after administration, 3 and 10 mg/kg SR141716 maintained their decreasing effect on the sensitivity to the stimulation as shown by the significant increase of the M50, however, the maximal response was restored to the basal value. A decrease in self-stimulation intensity produced an effect comparable to the one observed 30 min after either 3 or 10 mg/kg SR141716, while cocaine (5 and 10 mg/kg) produced the opposite effect. Neither condition affected the rate-frequency curve measured 3 h later. CONCLUSIONS: In accordance with recent observations, these experiments suggest that the endogenous cannabinoid system facilitates the perception or the effects of positive reinforcers. They also suggest that this neurochemical system could be a target of interest for treating psychopathologies implicating the reinforcing system. More... »

PAGES

254-259

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002130100804

DOI

http://dx.doi.org/10.1007/s002130100804

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041841621

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11605080


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cocaine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Depression, Chemical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Electric Stimulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Cannabinoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reinforcement (Psychology)", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Self Stimulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin Uptake Inhibitors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Laboratoire de Psychobiologie des Comportements Adaptatifs, Domaine de Carreire, Rue Camille Saint-Sa\u00ebns, 33077 Bordeaux, France, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Deroche-Gamonet", 
        "givenName": "V.", 
        "id": "sg:person.01162567427.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162567427.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Laboratoire de Psychobiologie des Comportements Adaptatifs, Domaine de Carreire, Rue Camille Saint-Sa\u00ebns, 33077 Bordeaux, France, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Moal", 
        "givenName": "M.", 
        "id": "sg:person.0675651375.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675651375.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Laboratoire de Psychobiologie des Comportements Adaptatifs, Domaine de Carreire, Rue Camille Saint-Sa\u00ebns, 33077 Bordeaux, France, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Piazza", 
        "givenName": "P.", 
        "id": "sg:person.010676170744.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010676170744.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sanofi-Synth\u00e9labo, 371 rue du Pr. Joseph Blayac, 34184 Montpellier, France, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soubri\u00e9", 
        "givenName": "P.", 
        "type": "Person"
      }
    ], 
    "datePublished": "2001-09", 
    "datePublishedReg": "2001-09-01", 
    "description": "RATIONALE: The endogenous cannabinoid system is thought to play a role in reinforcement processes.\nOBJECTIVES: We tested the effects of five doses of the cannabinoid receptor 1 (CB1) antagonist SR141716 [0, 0.3, 1, 3 and 10 mg/kg intraperitoneal (IP)] on intracranial self-stimulation at the level of the median forebrain bundle (MFB). Self-stimulation was assessed 30 min and 210 min after SR141716 administration. We compared the effect of SR141716 with the effect of a decrease in the magnitude of stimulation (-100 microA) and the effects of a cocaine injection (1, 5 and 10 mg/kg IP).\nMETHODS: a protocol of rate-frequency curve for self-stimulation was applied. Two rate-frequency curves were established daily, 3 h apart. The frequency required to produce half-maximal performance (M50) and the maximal performance (RMax) were used as the parameters to characterize the rate-frequency functions.\nRESULTS: SR141716 decreased the sensitivity to the electrical brain stimulation. SR141716 induced a shift to the right of the rate-frequency curve. This effect depended on the dose administered and the time after injection. Thirty minutes after the injection, 1, 3 and 10 mg/kg SR141716 induced a significant decrease in sensitivity to electrical stimulation, as shown by an elevation in the M50 value. RMax showed a tendency to decrease with increasing doses. At 210 min after administration, 3 and 10 mg/kg SR141716 maintained their decreasing effect on the sensitivity to the stimulation as shown by the significant increase of the M50, however, the maximal response was restored to the basal value. A decrease in self-stimulation intensity produced an effect comparable to the one observed 30 min after either 3 or 10 mg/kg SR141716, while cocaine (5 and 10 mg/kg) produced the opposite effect. Neither condition affected the rate-frequency curve measured 3 h later.\nCONCLUSIONS: In accordance with recent observations, these experiments suggest that the endogenous cannabinoid system facilitates the perception or the effects of positive reinforcers. They also suggest that this neurochemical system could be a target of interest for treating psychopathologies implicating the reinforcing system.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s002130100804", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085440", 
        "issn": [
          "0033-3158", 
          "1432-2072"
        ], 
        "name": "Psychopharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "157"
      }
    ], 
    "name": "SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats", 
    "pagination": "254-259", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c7507c7ac204dd2f07c3861c17bf8819b552198766b108a2356f2aac27a0ca62"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11605080"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7608025"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002130100804"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041841621"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002130100804", 
      "https://app.dimensions.ai/details/publication/pub.1041841621"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000490.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s002130100804"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002130100804'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002130100804'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002130100804'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002130100804'


 

This table displays all metadata directly associated to this object as RDF triples.

154 TRIPLES      20 PREDICATES      44 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002130100804 schema:about N01ef515e7e224f05b5122673f3e9567a
2 N189df8a114cb483d9c7e86e1eb97a2ca
3 N2ac8d6481c5f4547bc33f722151eb25c
4 N2dbede062bc748f49794f370b4071bdf
5 N3d37e0ae42a4450e81644c4775bf42b9
6 N3ec4e8a1c4064293b5f674fd84e3c59d
7 N512fb56154834f1b961ac57bc421b26d
8 N70f0f492d5394f38b8282d54086e314c
9 N7cf3136c37f0421fabf358e4b816c186
10 N9ac756ffa1e54dcdacdbcb4d43e6e8d2
11 Na3768c1037dd43dc8ef8a26ef1af9f8d
12 Nca275eff72754892b402c88c70c6a50d
13 Ne69dd0d868a14f4ebbaaa169223f7a85
14 Ne9459d60c9f34a19a811a2e10793c9ec
15 Nf0b791414e9247c8aa597fa92d2d157d
16 anzsrc-for:11
17 anzsrc-for:1109
18 schema:author N6a694d8a70484b2fa6618bb3dbf59e81
19 schema:datePublished 2001-09
20 schema:datePublishedReg 2001-09-01
21 schema:description RATIONALE: The endogenous cannabinoid system is thought to play a role in reinforcement processes. OBJECTIVES: We tested the effects of five doses of the cannabinoid receptor 1 (CB1) antagonist SR141716 [0, 0.3, 1, 3 and 10 mg/kg intraperitoneal (IP)] on intracranial self-stimulation at the level of the median forebrain bundle (MFB). Self-stimulation was assessed 30 min and 210 min after SR141716 administration. We compared the effect of SR141716 with the effect of a decrease in the magnitude of stimulation (-100 microA) and the effects of a cocaine injection (1, 5 and 10 mg/kg IP). METHODS: a protocol of rate-frequency curve for self-stimulation was applied. Two rate-frequency curves were established daily, 3 h apart. The frequency required to produce half-maximal performance (M50) and the maximal performance (RMax) were used as the parameters to characterize the rate-frequency functions. RESULTS: SR141716 decreased the sensitivity to the electrical brain stimulation. SR141716 induced a shift to the right of the rate-frequency curve. This effect depended on the dose administered and the time after injection. Thirty minutes after the injection, 1, 3 and 10 mg/kg SR141716 induced a significant decrease in sensitivity to electrical stimulation, as shown by an elevation in the M50 value. RMax showed a tendency to decrease with increasing doses. At 210 min after administration, 3 and 10 mg/kg SR141716 maintained their decreasing effect on the sensitivity to the stimulation as shown by the significant increase of the M50, however, the maximal response was restored to the basal value. A decrease in self-stimulation intensity produced an effect comparable to the one observed 30 min after either 3 or 10 mg/kg SR141716, while cocaine (5 and 10 mg/kg) produced the opposite effect. Neither condition affected the rate-frequency curve measured 3 h later. CONCLUSIONS: In accordance with recent observations, these experiments suggest that the endogenous cannabinoid system facilitates the perception or the effects of positive reinforcers. They also suggest that this neurochemical system could be a target of interest for treating psychopathologies implicating the reinforcing system.
22 schema:genre research_article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N0d63e854c9ae43edb08384047fd99b99
26 Nf16aa0ffed0e4297ac21b32f5fa0e0e1
27 sg:journal.1085440
28 schema:name SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats
29 schema:pagination 254-259
30 schema:productId N1ab6e40d1e22413583215cd94af57305
31 N4a2a6d12d4d649e4bdf97c204bb22e58
32 Na569c579284f4f7b820c4f9c3c1a9d72
33 Nac38bd24167a4904b0a1fbf620ee7437
34 Nb80fb1e4f8424523a11432180bd97d76
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041841621
36 https://doi.org/10.1007/s002130100804
37 schema:sdDatePublished 2019-04-10T22:27
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N225fa68de7174f5bae92dc162ff5d055
40 schema:url http://link.springer.com/10.1007/s002130100804
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N01ef515e7e224f05b5122673f3e9567a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
45 schema:name Depression, Chemical
46 rdf:type schema:DefinedTerm
47 N0d63e854c9ae43edb08384047fd99b99 schema:issueNumber 3
48 rdf:type schema:PublicationIssue
49 N189df8a114cb483d9c7e86e1eb97a2ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
50 schema:name Rats, Sprague-Dawley
51 rdf:type schema:DefinedTerm
52 N1ab6e40d1e22413583215cd94af57305 schema:name dimensions_id
53 schema:value pub.1041841621
54 rdf:type schema:PropertyValue
55 N225fa68de7174f5bae92dc162ff5d055 schema:name Springer Nature - SN SciGraph project
56 rdf:type schema:Organization
57 N246b55f39858483e96021f874af6f104 schema:name Laboratoire de Psychobiologie des Comportements Adaptatifs, Domaine de Carreire, Rue Camille Saint-Saëns, 33077 Bordeaux, France, France
58 rdf:type schema:Organization
59 N2ac8d6481c5f4547bc33f722151eb25c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Cocaine
61 rdf:type schema:DefinedTerm
62 N2dbede062bc748f49794f370b4071bdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Rats
64 rdf:type schema:DefinedTerm
65 N3030c482916a4457a4d46b0e688129e0 rdf:first sg:person.0675651375.36
66 rdf:rest Nf59ae9aa0e014bb0844bc9475c0aaa50
67 N3d37e0ae42a4450e81644c4775bf42b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Brain
69 rdf:type schema:DefinedTerm
70 N3ec4e8a1c4064293b5f674fd84e3c59d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Serotonin Uptake Inhibitors
72 rdf:type schema:DefinedTerm
73 N450c927ed9044bd1a730abb08af6e47a rdf:first Ncc4c37949fa741a9ae5ca737e795b51e
74 rdf:rest rdf:nil
75 N4a2a6d12d4d649e4bdf97c204bb22e58 schema:name nlm_unique_id
76 schema:value 7608025
77 rdf:type schema:PropertyValue
78 N512fb56154834f1b961ac57bc421b26d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Self Stimulation
80 rdf:type schema:DefinedTerm
81 N6a694d8a70484b2fa6618bb3dbf59e81 rdf:first sg:person.01162567427.00
82 rdf:rest N3030c482916a4457a4d46b0e688129e0
83 N70f0f492d5394f38b8282d54086e314c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Male
85 rdf:type schema:DefinedTerm
86 N78f82b0bd84a4571aa73c2c003b0f69c schema:name Laboratoire de Psychobiologie des Comportements Adaptatifs, Domaine de Carreire, Rue Camille Saint-Saëns, 33077 Bordeaux, France, France
87 rdf:type schema:Organization
88 N7cf3136c37f0421fabf358e4b816c186 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Reinforcement (Psychology)
90 rdf:type schema:DefinedTerm
91 N9ac756ffa1e54dcdacdbcb4d43e6e8d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Receptors, Drug
93 rdf:type schema:DefinedTerm
94 Na3768c1037dd43dc8ef8a26ef1af9f8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Piperidines
96 rdf:type schema:DefinedTerm
97 Na569c579284f4f7b820c4f9c3c1a9d72 schema:name pubmed_id
98 schema:value 11605080
99 rdf:type schema:PropertyValue
100 Nac38bd24167a4904b0a1fbf620ee7437 schema:name doi
101 schema:value 10.1007/s002130100804
102 rdf:type schema:PropertyValue
103 Nb80fb1e4f8424523a11432180bd97d76 schema:name readcube_id
104 schema:value c7507c7ac204dd2f07c3861c17bf8819b552198766b108a2356f2aac27a0ca62
105 rdf:type schema:PropertyValue
106 Nc56181ded1d248209b18e1f98d8629d7 schema:name Laboratoire de Psychobiologie des Comportements Adaptatifs, Domaine de Carreire, Rue Camille Saint-Saëns, 33077 Bordeaux, France, France
107 rdf:type schema:Organization
108 Nca275eff72754892b402c88c70c6a50d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Electric Stimulation
110 rdf:type schema:DefinedTerm
111 Ncc4c37949fa741a9ae5ca737e795b51e schema:affiliation Nf201ffd409224a34a1f29f0e3df83199
112 schema:familyName Soubrié
113 schema:givenName P.
114 rdf:type schema:Person
115 Ne69dd0d868a14f4ebbaaa169223f7a85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Pyrazoles
117 rdf:type schema:DefinedTerm
118 Ne9459d60c9f34a19a811a2e10793c9ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Animals
120 rdf:type schema:DefinedTerm
121 Nf0b791414e9247c8aa597fa92d2d157d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Receptors, Cannabinoid
123 rdf:type schema:DefinedTerm
124 Nf16aa0ffed0e4297ac21b32f5fa0e0e1 schema:volumeNumber 157
125 rdf:type schema:PublicationVolume
126 Nf201ffd409224a34a1f29f0e3df83199 schema:name Sanofi-Synthélabo, 371 rue du Pr. Joseph Blayac, 34184 Montpellier, France, France
127 rdf:type schema:Organization
128 Nf59ae9aa0e014bb0844bc9475c0aaa50 rdf:first sg:person.010676170744.46
129 rdf:rest N450c927ed9044bd1a730abb08af6e47a
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
134 schema:name Neurosciences
135 rdf:type schema:DefinedTerm
136 sg:journal.1085440 schema:issn 0033-3158
137 1432-2072
138 schema:name Psychopharmacology
139 rdf:type schema:Periodical
140 sg:person.010676170744.46 schema:affiliation N246b55f39858483e96021f874af6f104
141 schema:familyName Piazza
142 schema:givenName P.
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010676170744.46
144 rdf:type schema:Person
145 sg:person.01162567427.00 schema:affiliation Nc56181ded1d248209b18e1f98d8629d7
146 schema:familyName Deroche-Gamonet
147 schema:givenName V.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162567427.00
149 rdf:type schema:Person
150 sg:person.0675651375.36 schema:affiliation N78f82b0bd84a4571aa73c2c003b0f69c
151 schema:familyName Le Moal
152 schema:givenName M.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675651375.36
154 rdf:type schema:Person
 




Preview window. Press ESC to close (or click here)


...